Eli Lilly and Company (LLY) Comes Out Against the Use of GLP-1 Drugs for "Cosmetic Weight Loss" as Obesity in the US Remains Near Record Highs : vimarsana.com

Eli Lilly and Company (LLY) is out today with a qualifier regarding the emergent probability of its breakthrough GLP-1 weight loss treatments ending up as "lifestyle drugs of choice."

Related Keywords

United States , Indiana , American , Gordon Hendry Gordonhendry , Eli Lilly , Capital Group , Google , Novo Nordisk , Facebook , Twitter , Indianapolis Based Eli , Gordon Hendry , Omega Therapeutics , Total Addressable Market ,